- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 3.99M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.58M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.96M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.58M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.27M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.72M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 3.46M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.54M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$20.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$18.06M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.10 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.28M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.55M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.81M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.83M |